August J. Moretti

CFO

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

FDMT

Current role

CFO

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2022	4D Molecular Therapeutics, Inc. (FDMT)	Chief Financial Officer	$459,644	—	—	$1,508,100	$192,696	$13,500	$2,173,940
2021	4D Molecular Therapeutics, Inc. (FDMT)	Chief Financial Officer	$435,000	—	—	$2,048,585	$139,200	$13,000	$2,635,785
2020	4D Molecular Therapeutics, Inc. (FDMT)	Chief Financial Officer	$399,712	—	—	—	$220,050	$13,000	$632,762
2019	4D Molecular Therapeutics, Inc. (FDMT)	Chief Financial Officer	$374,242	—	—	$1,661,243	$89,725	$12,500	$2,137,710

No earnings-call appearances or filed executive changes recorded yet.